Proteinuria  >>  Tekturna (aliskiren)  >>  Phase 4
Welcome,         Profile    Billing    Logout  

6 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Tekturna (aliskiren) / PDL
ALIPRES, NCT01219413: Influence of Aliskiren on Proteinuria

Checkmark P4 Data
Jan 2012 - Jan 2012: P4 Data
Completed
4
16
Europe
Aliskiren, Perindopril, Rasilez 300 mg, Prestarium 10 mg
Medical University of Gdansk
Chronic Kidney Disease, Proteinuria, Blood Pressure
07/10
09/10
NCT00922311: Aliskiren for Proteinuric IgAN Despite Angiotensin Blockade

Checkmark Data
Mar 2011 - Mar 2011: Data
Completed
4
25
RoW
Aliskiren, Rasilez
The University of Hong Kong, Queen Mary Hospital, Hong Kong, United Christian Hospital
IgA Nephropathy
12/10
12/10
NCT01541267: The Effect of Various Types of the Renin-angiotensin-aldosterone System Blockade on Proteinuria

Completed
4
20
Europe
aliskiren, eplerenon, telmisartan
Medical University of Gdansk
Chronic Kidney Disease, Proteinuria
05/11
11/11
NCT00961207: Triple Blockade of the Renin Angiotensin Aldosterone System in Diabetic (Type 1&2) Proteinuric Patients

Terminated
4
2
US
Aliskiren, Tekturna
John H. Stroger Hospital
Microalbuminuria, Macroalbuminuric Diabetic Nephropathy, Diabetes, Proteinuria, Albuminuria
07/12
09/12
NCT01150201: Aliskiren Combined With Losartan in Proteinuric, Non-diabetic Chronic Kidney Disease

Completed
4
80
RoW
Aliskiren, Rasilez, Losartan, Cozaar
The University of Hong Kong
Kidney Disease
08/14
08/14
RASQAL, NCT01827202: RAS Quantification in Patients With Aliskiren or Candesartan

Completed
4
24
Europe
RAS blockade discontinuation, Aliskiren, Rasilez, Candesartan, Atacand
Medical University of Vienna
Hypertension, Chronic Kidney Disease, Proteinuria
02/16
02/16

Download Options